Verified peer comparison

Evolv Technologies Holdings vs Karyopharm Therapeutics Financial Comparison

Direct answer

Evolv Technologies Holdings and Karyopharm Therapeutics are compared on the same basis.

The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage

Get free Evolv Technologies Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Evolv Technologies Holdings Revenue
145,905,000 USD
Karyopharm Therapeutics Revenue
146,067,000 USD
Evolv Technologies Holdings Operating income
-44,801,000 USD
Karyopharm Therapeutics Operating income
-90,707,000 USD